Here, using CRISPR/Cas9 knockout of Gp78 in HT-1080 fibrosarcoma cells, Gp78 is shown to promote both basal and damage-induced mitophagy leading to ATG5-dependent reduction in mitochondrial mass, increased mitochondrial potential and reduced mitochondrial ROS. The gene discussed is AMFR; the disease is fibrosarcoma.